Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | The importance of patient perspectives during treatment journeys

Jerry Spivak • 26 Aug 2022
Texas MPN Workshop 2022
Myelofibrosis Myeloproliferative Neoplasms

Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, comments on the importance of the patient’s perspective when treating those with myeloproliferative neoplasms (MPNs), and further highlights the value of engaging with and listening to patients during their treatment journey. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

More from Jerry Spivak

Polycythemia vera: myths, mechanisms, and management
Jerry Spivak • 24 Nov 2022
Polycythemia vera: disease outcomes, unmet needs and therapeutic strategies
Jerry Spivak • 10 Nov 2022
5:21
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
Jerry Spivak • 26 Aug 2022
6:04
The need to improve diagnostic criteria in PV and other challenges in the field
Jerry Spivak • 26 Aug 2022

Related Videos

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
2:52
JAK inhibitor combination therapy for the treatment of myelofibrosis
Ruben Mesa • 9 Dec 2023
1:30
XPORT-MF-034: selinexor + ruxolitinib combination therapy for MF
John Mascarenhas • 10 Dec 2023
1:38
Pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
John Mascarenhas • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals